Home > News > VCs to Nanotech: Don't Call Us!
February 27th, 2006
VCs to Nanotech: Don't Call Us!
Today saw the launch of our new report looking at how VCs around the world are funding nanotech, and it turns out that they aren't! Despite the hype, we see around 0.14% of US VC money going into nanotech, and an even less significant fraction in the rest of the world.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014